Literature DB >> 8841004

SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals.

F Martini1, L Iaccheri, L Lazzarin, P Carinci, A Corallini, M Gerosa, P Iuzzolino, G Barbanti-Brodano, M Tognon.   

Abstract

SV40 T antigen (Tag) coding sequences were detected by PCR amplification followed by Southern blot hybridization in human brain tumors and tumor cell lines, as well as in peripheral blood cells and sperm fluids of healthy donors. SV40 early region sequences were found in 83% of choroid plexus papillomas, 73% of ependymomas, 47% of astrocytomas, 33% of glioblastoma multiforme cases, 14% of meningiomas, 50% of glioblastoma cell lines, and 33% of astrocytoma cell lines and in 23% of peripheral blood cell samples and 45% of sperm fluids from normal individuals. None of the 13 normal brain tissues were positive for SV40 DNA, nor were seven oligodendrogliomas, two spongioblastomas, one neuroblastoma, one meningioma, or four neuroblastoma cell lines. Expression of SV40 early region was found by reverse transcription PCR, and SV40-specific Tag was detected by indirect immunofluorescence in glioblastoma cell lines. DNA sequence analysis, performed in four positive samples, confirmed that the amplified PCR products belong to the SV40 early region. Sixty-one % of the neoplastic patients positive for SV40 sequences had an age excluding exposure to SV40-contaminated polio vaccines, suggesting a contagious transmission of SV40. The possible role of SV40 Tag in the etiopathogenesis of human brain tumors and the spread of SV40 by horizontal infection in the human population are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841004

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

Review 1.  Convicting a human tumor virus: guilt by association?

Authors:  J A Blaho; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 2.  Brain tumors and polyomaviruses.

Authors:  Sidney Croul; Jessica Otte; Kamel Khalili
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

3.  Simian virus 40 infection of humans.

Authors:  Robert L Garcea; Michael J Imperiale
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  The JC and BK human polyoma viruses appear to be recent introductions to some South American Indian tribes: there is no serological evidence of cross-reactivity with the simian polyoma virus SV40.

Authors:  E O Major; J V Neel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

5.  Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease.

Authors:  J A Lednicky; A S Arrington; A R Stewart; X M Dai; C Wong; S Jafar; M Murphey-Corb; J S Butel
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Association of autism with polyomavirus infection in postmortem brains.

Authors:  Carla Lintas; Laura Altieri; Federica Lombardi; Roberto Sacco; Antonio M Persico
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

Review 7.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  Inability of simian virus 40 to establish productive infection of lymphoblastic cell lines.

Authors:  Sophie Shaikh; Christine Skoczylas; Richard Longnecker; Kathleen Rundell
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters.

Authors:  Niraj C Patel; Steven J Halvorson; Vojtech Sroller; Amy S Arrington; Connie Wong; E O'Brian Smith; Regis A Vilchez; Janet S Butel
Journal:  Virology       Date:  2009-01-31       Impact factor: 3.616

Review 10.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.